Abstract 2505: Neurotensin receptor antagonist, SR48692, sensitizes prostate cancer cells to radiationin vitroandin vivo

Mapping Intimacies ◽

10.1158/1538-7445.am2011-2505 ◽

2011 ◽

Author(s):

Eli V. Casarez ◽

John O. DaSilva ◽

Nicholas C.K. Valerie ◽

Suresh Anaganti ◽

Marya E. Dunlap-Brown ◽

...

Keyword(s):

Prostate Cancer ◽

Receptor Antagonist ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Neurotensin Receptor

Download Full-text

Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells

Cellular Signalling ◽

10.1016/j.cellsig.2004.01.011 ◽

2004 ◽

Vol 16 (8) ◽

pp. 959-965 ◽

Cited By ~ 5

Author(s):

Chung-Ren Jan ◽

Yu-Ying Chao

Keyword(s):

Prostate Cancer ◽

Receptor Antagonist ◽

Cancer Cells ◽

Platelet Activation ◽

Human Prostate ◽

Human Prostate Cancer ◽

Prostate Cancer Cells ◽

Platelet Activation Factor ◽

Activation Factor

Download Full-text

The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells

Journal of Cellular Biochemistry ◽

10.1002/jcb.28929 ◽

2019 ◽

Vol 120 (10) ◽

pp. 16711-16722

Author(s):

Alexander Abazid ◽

Benedikt Martin ◽

Anja Choinowski ◽

Rhiannon V. McNeill ◽

Lars‐Ove Brandenburg ◽

...

Keyword(s):

Prostate Cancer ◽

Estrogen Receptor ◽

Androgen Receptor ◽

Heat Shock ◽

Heat Shock Protein ◽

Receptor Antagonist ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Protein System ◽

Androgen Receptor Antagonist

Download Full-text

Abstract 1702: Androgen receptor antagonist bicalutamide sensitizes androgen-independent prostate cancer cells to mTOR inhibitor rapamycin by regulating phosphorylation of translation initiation suppressor eIF4E-binding protein 1 (4E-BP1)

10.1158/1538-7445.am10-1702 ◽

2010 ◽

Author(s):

Swagata Bose ◽

Yu Wang ◽

Salma Siddiqui ◽

Benjamin Mooso ◽

Ruth Vinall ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Translation Initiation ◽

Mtor Inhibitor ◽

Binding Protein ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist ◽

Androgen Independent

Download Full-text

A bufadienolide derived androgen receptor antagonist with inhibitory activities against prostate cancer cells

Chemico-Biological Interactions ◽

10.1016/j.cbi.2013.10.020 ◽

2014 ◽

Vol 207 ◽

pp. 16-22 ◽

Cited By ~ 12

Author(s):

Hai-Yan Tian ◽

Xiao-Feng Yuan ◽

Lu Jin ◽

Juan Li ◽

Cheng Luo ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist ◽

Inhibitory Activities

Download Full-text

The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2007.03.116 ◽

2007 ◽

Vol 357 (2) ◽

pp. 341-346 ◽

Cited By ~ 30

Author(s):

Chih-pin Chuu ◽

Rou-Yu Chen ◽

Richard A. Hiipakka ◽

John M. Kokontis ◽

Karen V. Warner ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Receptor Agonist ◽

Liver X Receptor ◽

Human Prostate Cancer ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist ◽

Liver X Receptor Agonist

Download Full-text

The Specific Neurotensin Receptor (ntr1) Antagonist, Sr48692, Sensitizes Prostate Cancer Cells to Ionizing Radiation, in Both In Vitro and In Vivo Models

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.1282 ◽

2009 ◽

Vol 75 (3) ◽

pp. S561

Author(s):

J.M. Larner ◽

J. Dziegielewski ◽

B. Pemberton ◽

M. Dunlap-Brown ◽

S. Parsons ◽

...

Keyword(s):

Prostate Cancer ◽

Ionizing Radiation ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

In Vivo Models ◽

Neurotensin Receptor

Download Full-text

Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT Corepressors

Cancer Research ◽

10.1158/0008-5472.can-07-0617 ◽

2007 ◽

Vol 67 (17) ◽

pp. 8388-8395 ◽

Cited By ~ 66

Author(s):

Myles C. Hodgson ◽

Inna Astapova ◽

Anthony N. Hollenberg ◽

Steven P. Balk

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist

Download Full-text

Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway

Chemico-Biological Interactions ◽

10.1016/j.cbi.2017.07.023 ◽

2017 ◽

Vol 275 ◽

pp. 22-34 ◽

Cited By ~ 7

Author(s):

S. Divakar ◽

K. Saravanan ◽

P. Karthikeyan ◽

R. Elancheran ◽

S. Kabilan ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Akt Pathway ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist ◽

Cancer Activity ◽

Androgen Independent

Download Full-text

Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells

Investigational New Drugs ◽

10.1007/s10637-020-00901-w ◽

2020 ◽

Vol 38 (5) ◽

pp. 1292-1302 ◽

Cited By ~ 2

Author(s):

Feng Qu ◽

Yue Gu ◽

Qizhi Wang ◽

Mingzhe He ◽

Fang Zhou ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Androgen Receptor Antagonist ◽

Metabolomic Profiling

Download Full-text

279: Inhibition of Cyclooxygenase-2 Pathway Overcomes the Heat-Resistance in Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30544-5 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 93-93

Author(s):

Makoto Sumitomo ◽

Kenji Kuroda ◽

Takako Asano ◽

Akio Horiguchi ◽

Keiichi Ito ◽

...

Keyword(s):

Prostate Cancer ◽

Heat Resistance ◽

Cancer Cells ◽

Cyclooxygenase 2 ◽

Prostate Cancer Cells

Download Full-text